-
Signature
-
/s/ Jonathan Ornstein
-
Stock symbol
-
MESA
-
Transactions as of
-
Jun 1, 2024
-
Transactions value $
-
-$60,680
-
Form type
-
4
-
Date filed
-
6/4/2024, 05:15 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
MESA |
Common Stock |
Options Exercise |
$0 |
+27.2K |
+3.58% |
$0.00 |
788K |
Jun 1, 2024 |
Direct |
|
transaction |
MESA |
Common Stock |
Options Exercise |
$0 |
+67.5K |
+8.56% |
$0.00 |
856K |
Jun 1, 2024 |
Direct |
|
transaction |
MESA |
Common Stock |
Options Exercise |
$0 |
+24.1K |
+2.82% |
$0.00 |
880K |
Jun 1, 2024 |
Direct |
|
transaction |
MESA |
Common Stock |
Tax liability |
-$60.7K |
-49.7K |
-5.65% |
$1.22 |
830K |
Jun 1, 2024 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
MESA |
Restricted Stock Award |
Options Exercise |
$0 |
-27.2K |
-11.61% |
$0.00 |
207K |
Jun 1, 2024 |
Common stock |
27.2K |
$0.00 |
Direct |
F1 |
transaction |
MESA |
Restricted Stock Award |
Options Exercise |
$0 |
-67.5K |
-32.54% |
$0.00 |
140K |
Jun 1, 2024 |
Common stock |
67.5K |
$0.00 |
Direct |
F2 |
transaction |
MESA |
Restricted Stock Award |
Options Exercise |
$0 |
-24.1K |
-17.26% |
$0.00 |
116K |
Jun 1, 2024 |
Common stock |
24.1K |
$0.00 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: